Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
octreotide somatostatin receptor type 2 NA Successful target TTD , DGIDB Flushing[MeSHID:D005483]
Neoplasms[MeSHID:D009369]
Diarrhea[MeSHID:D003967]
Carcinoid Tumor[MeSHID:D002276]
Vipoma[MeSHID:D003969]
Acromegaly[MeSHID:D000172]
Patient Discharge[MeSHID:D010351]
long-term care[MeSHID:D008134]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.72 approved unknown
octreotide somatostatin receptor type 2 NA Successful target TTD , DGIDB Flushing[MeSHID:D005483]
Neoplasms[MeSHID:D009369]
Diarrhea[MeSHID:D003967]
Carcinoid Tumor[MeSHID:D002276]
Vipoma[MeSHID:D003969]
Acromegaly[MeSHID:D000172]
Patient Discharge[MeSHID:D010351]
long-term care[MeSHID:D008134]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.72 approved agonist
octreotide somatostatin receptor small molecule NA drugbank Flushing[MeSHID:D005483]
Neoplasms[MeSHID:D009369]
Diarrhea[MeSHID:D003967]
Carcinoid Tumor[MeSHID:D002276]
Vipoma[MeSHID:D003969]
Acromegaly[MeSHID:D000172]
Patient Discharge[MeSHID:D010351]
long-term care[MeSHID:D008134]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational agonist
click here to return to the previous page